Filing Details

Accession Number:
0001708138-20-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-17 16:02:26
Reporting Period:
2020-06-15
Accepted Time:
2020-06-17 16:02:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697422 R. Christopher Fenimore 777 Old Saw Mill River Road
Tarrytown NY 10591
Vp Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-15 7,226 $52.03 20,323 No 4 M Direct
Common Stock Disposition 2020-06-15 3,670 $587.90 16,653 No 4 F Direct
Common Stock Acquisiton 2020-06-15 2,180 $30.63 18,833 No 4 M Direct
Common Stock Disposition 2020-06-16 112 $581.40 18,721 No 4 S Direct
Common Stock Disposition 2020-06-16 18 $582.69 18,703 No 4 S Direct
Common Stock Disposition 2020-06-16 111 $583.06 18,592 No 4 S Direct
Common Stock Disposition 2020-06-16 99 $584.62 18,493 No 4 S Direct
Common Stock Disposition 2020-06-16 130 $585.76 18,363 No 4 S Direct
Common Stock Disposition 2020-06-16 413 $586.54 17,950 No 4 S Direct
Common Stock Disposition 2020-06-16 373 $587.55 17,577 No 4 S Direct
Common Stock Disposition 2020-06-16 147 $588.80 17,430 No 4 S Direct
Common Stock Disposition 2020-06-16 153 $590.70 17,277 No 4 S Direct
Common Stock Disposition 2020-06-16 233 $591.61 17,044 No 4 S Direct
Common Stock Disposition 2020-06-16 214 $592.20 16,830 No 4 S Direct
Common Stock Disposition 2020-06-16 109 $593.25 16,721 No 4 S Direct
Common Stock Disposition 2020-06-16 747 $594.35 15,974 No 4 S Direct
Common Stock Disposition 2020-06-16 403 $595.50 15,571 No 4 S Direct
Common Stock Disposition 2020-06-16 294 $596.36 15,277 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2020-06-15 2,180 $0.00 2,180 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-06-15 7,226 $0.00 7,226 $52.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-14 No 4 M Direct
0 2021-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,430 Indirect By 401(k) Plan
Common Stock 1,897 Indirect By Trust
Common Stock 509 Indirect by 2017 GRAT
Common Stock 2,284 Indirect by 2018 GRAT
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 112 shares of Company stock on June 16, 2020 at prices ranging from $581.39 to $581.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 18 shares of Company stock on June 16, 2020 at prices ranging from $582.53 to $582.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 130 shares of Company stock on June 16, 2020 at prices ranging from $585.11 to $585.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 413 shares of Company stock on June 16, 2020 at prices ranging from $586.29 to $586.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 373 shares of Company stock on June 16, 2020 at prices ranging from $587.05 to $587.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 147 shares of Company stock on June 16, 2020 at prices ranging from $588.60 to $588.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 153 shares of Company stock on June 16, 2020 at prices ranging from $590.00 to $590.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 233 shares of Company stock on June 16, 2020 at prices ranging from $591.06 to $591.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 214 shares of Company stock on June 16, 2020 at prices ranging from $592.01 to $592.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 747 shares of Company stock on June 16, 2020 at prices ranging from $594.05 to $594.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 403 shares of Company stock on June 16, 2020 at prices ranging from $595.08 to $595.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  13. Represents volume-weighted average price of sales of 294 shares of Company stock on June 16, 2020 at prices ranging from $596.00 to $596.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 16, 2020 at each separate price.
  14. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
  15. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  16. The stock option award vests in four equal annual installments, commencing one year after the date of grant.